These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2148896)

  • 1. Depression and selective serotonin reuptake inhibitors.
    Westwick F
    Br J Hosp Med; 1990 Nov; 44(5):367. PubMed ID: 2148896
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
    J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel selective serotonin reuptake inhibitors, Part II.
    J Clin Psychiatry; 1992 Jun; 53(6):216-21. PubMed ID: 1535073
    [No Abstract]   [Full Text] [Related]  

  • 6. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects: priapism caused by paroxetine].
    Bertholon F; Krajewski Y; el Allali A
    Ann Med Psychol (Paris); 1996 May; 154(2):145-6; discussion 146-7. PubMed ID: 8694403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. If at first you do succeed.
    Lancet; 1991 Mar; 337(8742):650-1. PubMed ID: 1671998
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM; Naylor GJ; Murtagh M; Winslow G
    Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772
    [No Abstract]   [Full Text] [Related]  

  • 15. Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy.
    Peselow ED; Robins CJ; Sanfilipo MP; Block P; Fieve RR
    J Abnorm Psychol; 1992 Aug; 101(3):479-86. PubMed ID: 1386856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 17. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic issues in the treatment of depression.
    Cohen LJ
    Formulary; 1995 Sep; 30 Suppl 1():S20-5. PubMed ID: 10151739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Brøsen K; Eshøj O; Mogensen EF
    Pain; 1990 Aug; 42(2):135-144. PubMed ID: 2147235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.